Skip to main content
. 2018 Jun 20;21(2):206–212. doi: 10.4048/jbc.2018.21.2.206

Table 1. Characteristics of patients by tumor laterality.

Characteristic All patients (n = 4,333)
No. (%)
Right-sided (n = 2,256)
No. (%)
Left-sided (n = 2,077)
No. (%)
p-value
Year of RT 0.434
 1996–2000 367 (8.5) 202 (9.0) 165 (7.9)
 2001–2005 1,333 (30.8) 683 (30.3) 650 (31.3)
 2006–2010 2,633 (60.8) 1,371 (60.8) 1,262 (60.8)
Age (yr) 0.981
 < 40 733 (16.9) 379 (16.8) 354 (17.0)
 40–49 1,900 (43.8) 996 (44.1) 904 (43.5)
 50–59 1,199 (27.7) 622 (27.6) 577 (27.8)
 ≥ 60 501 (11.6) 259 (11.5) 242 (11.7)
BMI (kg/m2) 0.567
 Unknown 439 (10.1) 218 (9.7) 221 (10.6)
 < 25 2,795 (64.5) 1,463 (64.8) 1,332 (64.1)
 ≥ 25 1,099 (25.4) 575 (25.5) 524 (25.2)
Smoking 0.247
 Unknown 856 (19.8) 454 (20.1) 402 (19.4)
 Yes 92 (2.1) 55 (2.4) 37 (1.8)
 No 3,385 (78.1) 1,747 (77.4) 1,638 (78.9)
Hyperlipidemia 0.465
 Yes 335 (7.7) 168 (7.4) 167 (8.0)
 No 3,998 (92.3) 2,088 (92.6) 1,910 (92.0)
Hypertension 0.257
 Yes 254 (5.9) 141 (6.3) 113 (5.4)
 No 4,079 (94.1) 2,115 (93.8) 1,964 (94.6)
Diabetes 0.845
 Yes 201 (4.6) 106 (4.7) 95 (4.6)
 No 4,132 (95.4) 2,150 (95.3) 1,982 (95.4)
pT stage 0.643
 Tis 510 (11.8) 264 (11.7) 246 (11.8)
 T1 2,571 (59.3) 1,327 (58.8) 1,244 (59.9)
 T2 1,158 (26.7) 609 (27.0) 549 (26.4)
 T3 86 (2.0) 51 (2.3) 35 (1.7)
 T4 8 (0.2) 5 (0.2) 3 (0.1)
pN stage 0.592
 N0 3,041 (70.2) 1,578 (69.9) 1,463 (70.4)
 N1 967 (22.3) 506 (22.4) 461 (22.2)
 N2 244 (5.6) 134 (5.9) 110 (5.3)
 N3 81 (1.9) 38 (1.7) 43 (2.1)
Chemotherapy 0.234
 Yes 2,606 (60.1) 1,376 (61.0) 1,230 (59.2)
 No 1,727 (39.9) 880 (39.0) 847 (40.8)
Anthracycline 0.250
 Yes 1,992 (46.0) 1,056 (46.8) 936 (45.1)
 No 2,341 (54.0) 1,200 (53.2) 1,141 (54.9)
Trastuzumab 0.593
 Yes 206 (4.8) 111 (4.9) 95 (4.6)
 No 4,127 (95.2) 2,145 (95.1) 1,982 (95.4)

RT=radiotherapy; BMI=body mass index.